- Home
- ALF vs LXEO Comparison
ALF vs LXEO Comparison
Compare ALF & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALF
- LXEO
- Stock Information
- Founded
- ALF 2024
- LXEO 2017
- Country
- ALF United States
- LXEO United States
- Employees
- ALF N/A
- LXEO N/A
- Industry
- ALF
- LXEO
- Sector
- ALF
- LXEO
- Exchange
- ALF NYSE
- LXEO Nasdaq
- Market Cap
- ALF 360.5M
- LXEO 341.5M
- IPO Year
- ALF 2024
- LXEO 2023
- Fundamental
- Price
- ALF $10.03
- LXEO $8.66
- Analyst Decision
- ALF
- LXEO Strong Buy
- Analyst Count
- ALF 0
- LXEO 7
- Target Price
- ALF N/A
- LXEO $22.14
- AVG Volume (30 Days)
- ALF 78.4K
- LXEO 372.9K
- Earning Date
- ALF 01-01-0001
- LXEO 11-21-2024
- Dividend Yield
- ALF N/A
- LXEO N/A
- EPS Growth
- ALF N/A
- LXEO N/A
- EPS
- ALF N/A
- LXEO N/A
- Revenue
- ALF N/A
- LXEO N/A
- Revenue This Year
- ALF N/A
- LXEO N/A
- Revenue Next Year
- ALF N/A
- LXEO N/A
- P/E Ratio
- ALF N/A
- LXEO N/A
- Revenue Growth
- ALF N/A
- LXEO N/A
- 52 Week Low
- ALF $9.96
- LXEO $8.39
- 52 Week High
- ALF $10.08
- LXEO $22.33
- Technical
- Relative Strength Index (RSI)
- ALF N/A
- LXEO 35.15
- Support Level
- ALF N/A
- LXEO $8.39
- Resistance Level
- ALF N/A
- LXEO $10.88
- Average True Range (ATR)
- ALF 0.00
- LXEO 0.66
- MACD
- ALF 0.00
- LXEO 0.01
- Stochastic Oscillator
- ALF 0.00
- LXEO 10.84
About ALF CENTURION ACQUISITION CORP
Centurion Acquisition Corp is a blank check company.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.